Thibaut Belmondo

Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients

Réda Chebani, F. Lombart, G. Chaby et al. · British Journal of Dermatology · 2023 · 38 citations

Identification of factors impairing exercise capacity after severe COVID-19 pulmonary infection: a 3-month follow-up of prospective COVulnerability cohort

Bruno Ribeiro Baptista, Thomas d’Humières, F. Schlemmer et al. · Respiratory Research · 2022 · 35 citations · Full text

Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients

Nicolas Chapuis, Nusaïbah Ibrahimi, Thibaut Belmondo et al. · EBioMedicine · 2022 · 35 citations · Full text

Auto-antibodies against type I IFNs in > 10% of critically ill COVID-19 patients: a prospective multicentre study

Romain Arrestier, Paul Bastard, Thibaut Belmondo et al. · Annals of Intensive Care · 2022 · 34 citations · Full text

Prolonged response after TPO-RA discontinuation in primary ITP: results of a prospective multicenter study

S. Guillet, Étienne Crickx, Imane Azzaoui et al. · Blood · 2023 · 27 citations